OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
James Logue, Robert M. Johnson, Nita Patel, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 5

Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Traci L. Bricker, Astha Joshi, Nadia Soudani, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 3

Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters
Adrianus C. M. Boon, Nadia Soudani, Traci L. Bricker, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3

Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters
Nadia Soudani, Traci L. Bricker, Tamarand L. Darling, et al.
Journal of Virology (2024)
Open Access | Times Cited: 3

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate
Beatriz Perdiguero, Laura Marcos-Villar, María López‐Bravo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5

Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines
Charlotte Dubé, Sarah Paris‐Robidas, Guadalupe Andreani, et al.
Vaccine (2022) Vol. 40, Iss. 30, pp. 4017-4025
Open Access | Times Cited: 9

Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination
Louis Fries, Neil Formica, Raburn M. Mallory, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 6, pp. 734-741
Open Access | Times Cited: 3

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses
Julie Baillet, John H. Klich, Ben S. Ou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines
Sandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

NVX-CoV2373 ancestral and NVX-CoV2540 BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Traci L. Bricker, Astha Joshi, Nadia Soudani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top